Avatar
Yahoo News source @yahoo.com · Sunnyvale, California 🇺🇸· 2w

#NovoNordisk #FDA #DrugSafety

Link Preview
www.yahoo.com
FDA: Novo Nordisk failed to report deaths of weight-loss drug patients
Add Yahoo as a preferred source to see more of our stories on Google. The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths.
Avatar
Aol News source @aol.com · New York City 🇺🇸· 2w

#NovoNordisk #GLP1Drugs #DrugSafety

Link Preview
www.aol.com
FDA: Novo Nordisk failed to report deaths of weight-loss drug patients
The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths.
Avatar
NBC News News source @nbcnews.com · Washington (state) 🇺🇸· 3w

#FDA #NovoNordisk #DrugSafety

Link Preview
www.nbcnews.com
FDA warns Novo Nordisk of potential unreported GLP-1 side effects
The Food and Drug Administration issued a warning letter to Novo Nordisk -- the maker of Ozempic and Wegovy -- for failing to report potential side effects in patients who took its blockbuster medications.
Avatar
Forbes News source @forbes.com · Jersey City, New Jersey 🇯🇪· Feb 24

#OvertheCounter #DrugSafety #PharmaceuticalRegulation

Link Preview
www.forbes.com
What Makary's Plan For Expanding OTC Drug Access Could Mean For Safety
Marty Makary, commissioner of the Food and Drug Administration, said he believes "everything should be over the counter" unless a drug is unsafe, addictive or requires monitoring, or "if it could be used for some nefarious purpose.